Surfactant [EPC]

Surfactant [EPC] was reported 1163 times

Drugs of the Surfactant [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NEONATAL PNEUMOTHORAX 18 0.3273
1 PULMONARY HAEMORRHAGE NEONATAL 28 0.3043
2 RESPIRATORY TRACT HAEMORRHAGE NEONATAL 2 0.2857
3 BLOODY AIRWAY DISCHARGE 4 0.2500
4 CARDIO-RESPIRATORY ARREST NEONATAL 12 0.1538
5 NEONATAL HYPOXIA 126 0.1524
6 NEONATAL INTESTINAL PERFORATION 5 0.1389
7 ENDOTRACHEAL INTUBATION COMPLICATION 80 0.1356
8 PANTOEA AGGLOMERANS TEST POSITIVE 1 0.1250
9 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 12 0.0845
10 DIVERTICULAR HERNIA 1 0.0667
11 NEONATAL RESPIRATORY FAILURE 33 0.0652
12 END-TIDAL CO2 DECREASED 3 0.0638
13 HAEMORRHAGE NEONATAL 3 0.0577
14 MENINGITIS NEONATAL 3 0.0545
15 NEURODEVELOPMENTAL DISORDER 36 0.0533
16 NEONATAL PNEUMONIA 12 0.0511
17 PREMATURE BABY DEATH 4 0.0488
18 BRONCHITIS PNEUMOCOCCAL 1 0.0476
19 BRADYCARDIA NEONATAL 58 0.0461
20 LISTERIA TEST POSITIVE 1 0.0455
21 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 22 0.0453
22 LATE METABOLIC ACIDOSIS OF NEWBORN 1 0.0417
23 CYANOSIS NEONATAL 26 0.0406
24 MECONIUM PERITONITIS 1 0.0400
25 AIRWAY PEAK PRESSURE INCREASED 6 0.0395
26 CONGENITAL EMPHYSEMA 1 0.0385
27 SCLEREMA 3 0.0370
28 INFANTILE APNOEA 30 0.0368
29 CARDIAC ARREST NEONATAL 5 0.0362
30 DRUG-DEVICE INTERACTION 4 0.0360
31 DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORN 1 0.0323
32 NEONATAL ANURIA 3 0.0316
33 STREPTOCOCCAL IDENTIFICATION TEST POSITIVE 1 0.0303
34 NECROTISING ENTEROCOLITIS NEONATAL 12 0.0296
35 BRONCHOPULMONARY DYSPLASIA 23 0.0286
36 ENTERITIS NECROTICANS 1 0.0278
37 RENAL FAILURE NEONATAL 6 0.0270
38 PULMONARY HAEMORRHAGE 207 0.0264
39 SEPSIS NEONATAL 20 0.0246
40 PATENT DUCTUS ARTERIOSUS REPAIR 1 0.0208
41 TRACHEAL INJURY 3 0.0204
42 NEONATAL MULTI-ORGAN FAILURE 1 0.0200
43 NEONATAL RESPIRATORY ACIDOSIS 3 0.0197
44 TRAUMATIC DELIVERY 1 0.0196
45 BASE EXCESS NEGATIVE 1 0.0189
46 DEATH NEONATAL 26 0.0187
47 BREATH SOUNDS ABSENT 2 0.0182
48 NEONATAL HEPATOMEGALY 1 0.0179
49 HYPOXIC ISCHAEMIC ENCEPHALOPATHY NEONATAL 1 0.0179
50 BRONCHIAL INJURY 1 0.0172
51 POSTHAEMORRHAGIC HYDROCEPHALUS 1 0.0172
52 CIRCULATORY FAILURE NEONATAL 1 0.0169
53 RENAL INTERSTITIAL FIBROSIS 1 0.0169
54 ANAEMIA NEONATAL 8 0.0166
55 NEONATAL DISORDER 26 0.0164
56 NEONATAL HYPOTENSION 6 0.0163
57 CHEST WALL RIGIDITY 1 0.0156
58 CENTRAL NERVOUS SYSTEM INJURY 1 0.0154
59 CEREBRAL HAEMORRHAGE NEONATAL 3 0.0142
60 CYSTIC LUNG DISEASE 2 0.0141
61 PULMONARY PNEUMATOCELE 1 0.0141
62 MECHANICAL VENTILATION COMPLICATION 2 0.0134
63 NEONATAL TACHYCARDIA 2 0.0129
64 PNEUMOPERICARDIUM 2 0.0116
65 NEONATAL INFECTION 4 0.0116
66 NEONATAL CARDIAC FAILURE 1 0.0111
67 CHEST EXPANSION DECREASED 1 0.0108
68 ACINETOBACTER BACTERAEMIA 2 0.0106
69 PERIVENTRICULAR LEUKOMALACIA 3 0.0106
70 CONGENITAL PNEUMONIA 1 0.0105
71 NEONATAL DYSPNOEA 1 0.0105
72 HYPERTENSION NEONATAL 1 0.0103
73 NEONATAL RESPIRATORY DISTRESS SYNDROME 36 0.0102
74 RENAL IMPAIRMENT NEONATAL 1 0.0099
75 THROMBOCYTOPENIA NEONATAL 4 0.0095
76 MECONIUM ASPIRATION SYNDROME 2 0.0095
77 ATELECTASIS NEONATAL 1 0.0093
78 NEONATAL ASPIRATION 3 0.0091
79 VERTICAL INFECTION TRANSMISSION 1 0.0088
80 CONTINUOUS POSITIVE AIRWAY PRESSURE 2 0.0087
81 INFANTILE APNOEIC ATTACK 2 0.0085
82 TRACHEAL HAEMORRHAGE 3 0.0085
83 NEONATAL ASPHYXIA 6 0.0085
84 PRODUCT GEL FORMATION 1 0.0082
85 NEONATAL HYPONATRAEMIA 1 0.0082
86 BACILLUS INFECTION 5 0.0079
87 HYPOTHERMIA NEONATAL 1 0.0070
88 PLACENTAL TRANSFUSION SYNDROME 1 0.0069
89 TRACHEAL OEDEMA 1 0.0068
90 PULMONARY AIR LEAKAGE 1 0.0066
91 PERSISTENT FOETAL CIRCULATION 4 0.0066
92 IMMATURE RESPIRATORY SYSTEM 1 0.0064
93 CONGENITAL GENITAL MALFORMATION 1 0.0063
94 ULTRASOUND ABDOMEN ABNORMAL 1 0.0062
95 ILEAL PERFORATION 4 0.0060
96 OXYGEN SATURATION INCREASED 2 0.0059
97 COUNTERFEIT DRUG ADMINISTERED 2 0.0058
98 NEAR DROWNING 1 0.0057
99 WEANING FAILURE 2 0.0055
100 CHEST TUBE INSERTION 1 0.0053
101 SUBCUTANEOUS EMPHYSEMA 5 0.0051
102 USE OF ACCESSORY RESPIRATORY MUSCLES 2 0.0048
103 NECROTISING COLITIS 6 0.0047
104 PNEUMOTHORAX 75 0.0047
105 PRODUCT DEPOSIT 7 0.0045
106 NEUTROPENIA NEONATAL 1 0.0045
107 INTRAVENTRICULAR HAEMORRHAGE 11 0.0044
108 RENAL CORTICAL NECROSIS 1 0.0043
109 DEPENDENCE ON OXYGEN THERAPY 2 0.0041
110 NEONATAL SEIZURE 1 0.0040
111 TRACHEAL OBSTRUCTION 1 0.0038
112 HYPERCAPNIA 11 0.0036
113 APNOEIC ATTACK 2 0.0035
114 NEONATAL RESPIRATORY DISTRESS 3 0.0032
115 RESPIRATORY DISORDER NEONATAL 5 0.0031
116 RESUSCITATION 5 0.0030
117 FLUID REPLACEMENT 1 0.0030
118 PULMONARY NECROSIS 1 0.0029
119 PNEUMONITIS CHEMICAL 1 0.0029
120 CHRONIC RESPIRATORY DISEASE 1 0.0028
121 BRAIN MALFORMATION 1 0.0028
122 CLONIC CONVULSION 2 0.0027
123 OXYGEN SUPPLEMENTATION 2 0.0027
124 MEDIASTINAL DISORDER 1 0.0027
125 BRONCHOPLEURAL FISTULA 1 0.0027
126 JAUNDICE NEONATAL 5 0.0026
127 FOETAL GROWTH RETARDATION 2 0.0026
128 NEONATAL TACHYPNOEA 1 0.0024
129 REFLUX LARYNGITIS 1 0.0023
130 FEEDING INTOLERANCE 1 0.0022
131 PNEUMOMEDIASTINUM 4 0.0022
132 CARBON DIOXIDE INCREASED 3 0.0022
133 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
134 OXYGEN CONSUMPTION INCREASED 5 0.0021
135 PATENT DUCTUS ARTERIOSUS 8 0.0020
136 VASCULAR CALCIFICATION 2 0.0019
137 CORYNEBACTERIUM INFECTION 1 0.0019
138 HYPOGLYCAEMIA NEONATAL 3 0.0019
139 INTERLEUKIN LEVEL INCREASED 1 0.0018
140 ENDOTRACHEAL INTUBATION 5 0.0018
141 SUSPECTED COUNTERFEIT PRODUCT 7 0.0018
142 BLOOD PH DECREASED 3 0.0018
143 INCORRECT STORAGE OF DRUG 3 0.0017
144 LARYNGEAL STENOSIS 1 0.0017
145 RESPIRATORY TRACT HAEMORRHAGE 1 0.0017
146 OXYGEN CONSUMPTION DECREASED 1 0.0017
147 PNEUMOPERITONEUM 3 0.0016
148 PRODUCT COMPLAINT 40 0.0016
149 APGAR SCORE LOW 2 0.0016
150 PNEUMONIA NECROTISING 1 0.0015
151 ENTEROCOCCUS TEST POSITIVE 1 0.0015
152 VULVAL DISORDER 1 0.0015
153 LIQUID PRODUCT PHYSICAL ISSUE 11 0.0015
154 FOAMING AT MOUTH 3 0.0015
155 GLYCOSURIA 2 0.0015
156 PNEUMOTHORAX SPONTANEOUS 1 0.0015
157 CEREBRAL CYST 1 0.0015
158 APNOEA 11 0.0014
159 PCO2 INCREASED 1 0.0014
160 ANAEMIA MACROCYTIC 3 0.0014
161 CATHETER SITE RELATED REACTION 1 0.0013
162 COAGULATION TEST ABNORMAL 1 0.0013
163 HYPERTROPHIC CARDIOMYOPATHY 2 0.0013
164 PRODUCT ADMINISTRATION ERROR 26 0.0013
165 LABORATORY TEST INTERFERENCE 1 0.0013
166 PULMONARY HYPOPLASIA 1 0.0013
167 PULMONARY HYPERTENSION 26 0.0012
168 PLACENTAL INSUFFICIENCY 1 0.0012
169 PERFORATION 1 0.0012
170 BACTERIAL SEPSIS 4 0.0012
171 BRADYCARDIA FOETAL 1 0.0012
172 OESOPHAGEAL PERFORATION 1 0.0012
173 OESOPHAGEAL RUPTURE 1 0.0012
174 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
175 BRONCHIOLITIS 4 0.0011
176 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
177 SMALL INTESTINAL PERFORATION 2 0.0011
178 HEPATIC CONGESTION 1 0.0011
179 MECHANICAL VENTILATION 2 0.0011
180 INTUSSUSCEPTION 1 0.0010
181 AGITATION NEONATAL 1 0.0010
182 PRESCRIBED OVERDOSE 20 0.0010
183 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
184 RESPIRATORY ACIDOSIS 4 0.0010
185 DROWNING 1 0.0010
186 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
187 PRODUCT COLOUR ISSUE 5 0.0010
188 CAPILLARY LEAK SYNDROME 2 0.0010
189 HYPOPERFUSION 1 0.0010
190 OXYGEN SATURATION DECREASED 52 0.0009
191 HYPOVENTILATION 3 0.0009
192 ACINETOBACTER INFECTION 1 0.0009
193 PRODUCT SELECTION ERROR 1 0.0009
194 KLEBSIELLA SEPSIS 1 0.0009
195 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
196 HYPOCHLORAEMIA 1 0.0009
197 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
198 LABILE BLOOD PRESSURE 1 0.0008
199 ILL-DEFINED DISORDER 50 0.0008
200 TUBERCULIN TEST POSITIVE 2 0.0008
201 INCREASED BRONCHIAL SECRETION 2 0.0008
202 LUNG OPACITY 2 0.0008
203 OBSTRUCTION 3 0.0008
204 OFF LABEL USE OF DEVICE 1 0.0007
205 MUCOUS MEMBRANE DISORDER 1 0.0007
206 OXYGEN SATURATION ABNORMAL 2 0.0007
207 CONNECTIVE TISSUE DISORDER 1 0.0007
208 RENAL INFARCT 1 0.0007
209 BLOOD PRESSURE IMMEASURABLE 1 0.0007
210 BRONCHIAL DISORDER 1 0.0006
211 HYPOTONIA NEONATAL 1 0.0006
212 DEVICE OCCLUSION 9 0.0006
213 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
214 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
215 CYANOSIS 10 0.0006
216 FUNGAEMIA 1 0.0006
217 INTESTINAL PERFORATION 7 0.0006
218 METABOLIC SYNDROME 1 0.0006
219 BRADYARRHYTHMIA 1 0.0006
220 PRODUCT COUNTERFEIT 1 0.0006
221 PSEUDOMONAL SEPSIS 1 0.0006
222 CONDUCTION DISORDER 1 0.0005
223 BRADYCARDIA 28 0.0005
224 HYPOPROTEINAEMIA 1 0.0005
225 ADRENAL DISORDER 1 0.0005
226 CARDIOPULMONARY FAILURE 2 0.0005
227 HYPERTRIGLYCERIDAEMIA 3 0.0005
228 GENE MUTATION 1 0.0005
229 EMPYEMA 1 0.0005
230 PREMATURE BABY 15 0.0005
231 HYPOSPADIAS 1 0.0005
232 DILATATION VENTRICULAR 1 0.0005
233 NOSOCOMIAL INFECTION 1 0.0005
234 TEMPERATURE REGULATION DISORDER 1 0.0004
235 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
236 CALCINOSIS 1 0.0004
237 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
238 DRUG ADMINISTRATION ERROR 13 0.0004
239 NO THERAPEUTIC RESPONSE 5 0.0004
240 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
241 SMALL FOR DATES BABY 2 0.0004
242 HYPERNATRAEMIA 2 0.0004
243 CATHETER SITE HAEMORRHAGE 1 0.0004
244 EXCORIATION 1 0.0004
245 SHOCK 9 0.0004
246 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
247 VENTRICULAR DYSFUNCTION 1 0.0004
248 MUCORMYCOSIS 1 0.0004
249 LOW BIRTH WEIGHT BABY 3 0.0004
250 INTESTINAL ISCHAEMIA 2 0.0004
251 NECROSIS 2 0.0004
252 CIRCULATORY COLLAPSE 6 0.0004
253 HAEMOTHORAX 1 0.0003
254 ELECTROLYTE IMBALANCE 4 0.0003
255 GASTROINTESTINAL NECROSIS 1 0.0003
256 RESPIRATORY FAILURE 25 0.0003
257 PULMONARY PAIN 1 0.0003
258 STRIDOR 1 0.0003
259 CARDIO-RESPIRATORY ARREST 14 0.0003
260 CENTRAL VENOUS CATHETERISATION 1 0.0003
261 RESPIRATORY DISTRESS 9 0.0003
262 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
263 HEART RATE DECREASED 11 0.0003
264 METABOLIC ACIDOSIS 10 0.0003
265 INCORRECT PRODUCT STORAGE 4 0.0003
266 SKIN INJURY 1 0.0003
267 HYPOTONIA 3 0.0003
268 ECCHYMOSIS 2 0.0003
269 REGURGITATION 1 0.0003
270 HEART DISEASE CONGENITAL 1 0.0003
271 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
272 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
273 HAEMORRHAGE INTRACRANIAL 4 0.0003
274 FACE INJURY 1 0.0003
275 HAEMODYNAMIC INSTABILITY 2 0.0003
276 ACUTE RESPIRATORY FAILURE 5 0.0003
277 PRODUCT QUALITY ISSUE 35 0.0003
278 TRICUSPID VALVE INCOMPETENCE 2 0.0003
279 EXPOSURE VIA BREAST MILK 1 0.0003
280 HYPERGLYCAEMIA 9 0.0002
281 PERITONITIS 5 0.0002
282 COAGULOPATHY 4 0.0002
283 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
284 POOR PERIPHERAL CIRCULATION 1 0.0002
285 ANURIA 2 0.0002
286 URINE OUTPUT DECREASED 2 0.0002
287 PULMONARY FUNCTION TEST DECREASED 1 0.0002
288 LUNG INFILTRATION 2 0.0002
289 TACHYPNOEA 3 0.0002
290 UNDERDOSE 16 0.0002
291 CARDIAC ARREST 18 0.0002
292 ISCHAEMIA 1 0.0002
293 BLOOD SODIUM DECREASED 4 0.0002
294 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
295 BRONCHOSPASM 3 0.0002
296 SEPSIS 23 0.0002
297 RENAL TUBULAR NECROSIS 2 0.0002
298 APPLICATION SITE BURN 1 0.0002
299 BREATH SOUNDS ABNORMAL 1 0.0002
300 STAPHYLOCOCCAL SEPSIS 1 0.0002
301 EXPIRED DRUG ADMINISTERED 1 0.0002
302 HYPOXIA 7 0.0002
303 EMPHYSEMA 2 0.0002
304 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
305 KLEBSIELLA INFECTION 1 0.0002
306 DYSPHORIA 1 0.0002
307 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
308 LUNG INFECTION 3 0.0002
309 MALABSORPTION 1 0.0002
310 DERMATITIS 4 0.0002
311 PALLOR 5 0.0002
312 HYDROCEPHALUS 1 0.0002
313 ASPIRATION 2 0.0002
314 HAEMOPTYSIS 5 0.0002
315 ANGIOPATHY 1 0.0002
316 VENTRICULAR SEPTAL DEFECT 1 0.0002
317 MULTI-ORGAN FAILURE 3 0.0002
318 ENTEROCOLITIS 1 0.0002
319 METABOLIC DISORDER 1 0.0002
320 RALES 1 0.0002
321 POST PROCEDURAL HAEMORRHAGE 2 0.0002
322 CAESAREAN SECTION 2 0.0002
323 MUSCLE RIGIDITY 2 0.0002
324 PROTHROMBIN TIME PROLONGED 1 0.0002
325 FOETAL GROWTH RESTRICTION 1 0.0002
326 PIGMENTATION DISORDER 1 0.0002
327 GENERALISED OEDEMA 2 0.0002
328 OLIGURIA 1 0.0002
329 APPLICATION SITE VESICLES 1 0.0002
330 CHOKING 3 0.0002
331 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
332 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
333 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
334 PNEUMONITIS 4 0.0001
335 RESPIRATION ABNORMAL 1 0.0001
336 LUNG DISORDER 7 0.0001
337 CEREBRAL HAEMORRHAGE 5 0.0001
338 INJECTION SITE HAEMATOMA 2 0.0001
339 PRODUCT DISPENSING ERROR 3 0.0001
340 MOUTH HAEMORRHAGE 1 0.0001
341 ASCITES 4 0.0001
342 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
343 HYPOPHOSPHATAEMIA 1 0.0001
344 RESPIRATORY DISORDER 4 0.0001
345 ACIDOSIS 1 0.0001
346 BOWEL MOVEMENT IRREGULARITY 1 0.0001
347 SKIN DISCOLOURATION 6 0.0001
348 PROCEDURAL COMPLICATION 1 0.0001
349 ATRIOVENTRICULAR BLOCK 1 0.0001
350 CONGENITAL ANOMALY 1 0.0001
351 POLYURIA 1 0.0001
352 DRUG LEVEL INCREASED 2 0.0001
353 EXPIRED PRODUCT ADMINISTERED 4 0.0001
354 BLOOD UREA INCREASED 2 0.0001
355 PSEUDOMONAS INFECTION 1 0.0001
356 RASH GENERALISED 3 0.0001
357 HYPERKALAEMIA 4 0.0001
358 RESPIRATORY RATE INCREASED 1 0.0001
359 PULMONARY OEDEMA 5 0.0001
360 HAEMOLYTIC ANAEMIA 1 0.0001
361 HYPOCALCAEMIA 2 0.0001
362 BLOOD PRESSURE DECREASED 7 0.0001
363 ATELECTASIS 1 0.0001
364 HAEMATOCRIT DECREASED 2 0.0001
365 BRAIN INJURY 1 0.0001
366 OFF LABEL USE 87 0.0001
367 PERITONITIS BACTERIAL 1 0.0001
368 HYPOTHERMIA 1 0.0001
369 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
370 HYPERBILIRUBINAEMIA 1 0.0001
371 PETECHIAE 1 0.0001
372 TRANSFUSION 1 0.0001
373 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
374 DECREASED ACTIVITY 1 0.0001
375 BLOOD CREATININE INCREASED 6 0.0001
376 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
377 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
378 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
379 C-REACTIVE PROTEIN INCREASED 3 0.0001
380 RESPIRATORY DEPRESSION 1 0.0001
381 INJECTION SITE URTICARIA 2 0.0001
382 UNEVALUABLE EVENT 6 0.0001
383 ANAPHYLACTIC SHOCK 2 0.0001
384 DEATH 65 0.0001
385 ADVERSE REACTION 1 0.0001
386 CARDIAC FAILURE 6 0.0001
387 BLOOD BILIRUBIN INCREASED 2 0.0001
388 DRUG TOXICITY 1 0.0001
389 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
390 PERIPHERAL COLDNESS 1 0.0001
391 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
392 HYPOMAGNESAEMIA 1 0.0001
393 CARDIOGENIC SHOCK 1 0.0001
394 HYPOKINESIA 1 0.0001
395 CARDIOMYOPATHY 1 0.0001
396 ABDOMINAL DISTENSION 7 0.0001
397 EJECTION FRACTION DECREASED 1 0.0001
398 PREMATURE DELIVERY 1 0.0001
399 DRUG INEFFECTIVE 81 0.0001
400 VENTRICULAR TACHYCARDIA 1 0.0001
401 CYTOMEGALOVIRUS INFECTION 1 0.0001
402 LEUKOPENIA 3 0.0001
403 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
404 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
405 CONDITION AGGRAVATED 18 0.0001
406 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
407 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
408 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
409 MEDICATION ERROR 3 0.0001
410 THROMBOCYTOPENIA 6 0.0001
411 BACTERIAL INFECTION 1 0.0001
412 CONVULSION 3 0.0001
413 PULMONARY FIBROSIS 1 0.0001
414 CHOLESTASIS 1 0.0001
415 POST PROCEDURAL COMPLICATION 1 0.0001
416 OVERDOSE 11 0.0001
417 HYPOTENSION 10 0.0000
418 PRODUCT PHYSICAL ISSUE 1 0.0000
419 RIB FRACTURE 1 0.0000
420 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
421 SEPTIC SHOCK 2 0.0000
422 GASTROINTESTINAL DISORDER 4 0.0000
423 PRODUCT AVAILABILITY ISSUE 1 0.0000
424 PERICARDIAL EFFUSION 1 0.0000
425 ARRHYTHMIA 2 0.0000
426 INFECTION 6 0.0000
427 INTERSTITIAL LUNG DISEASE 2 0.0000
428 LIVER INJURY 1 0.0000
429 PNEUMONIA ASPIRATION 1 0.0000
430 INJECTION SITE SWELLING 3 0.0000
431 HAEMOGLOBIN DECREASED 4 0.0000
432 HAEMATOMA 1 0.0000
433 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
434 ANHEDONIA 1 0.0000
435 PRODUCT USE ISSUE 7 0.0000
436 FEAR 1 0.0000
437 JAUNDICE 1 0.0000
438 PNEUMONIA 12 0.0000
439 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
440 RESPIRATORY ARREST 1 0.0000
441 ANAPHYLACTIC REACTION 2 0.0000
442 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
443 HYPONATRAEMIA 2 0.0000
444 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
445 RED BLOOD CELL COUNT DECREASED 1 0.0000
446 PRODUCT STORAGE ERROR 3 0.0000
447 ACUTE MYOCARDIAL INFARCTION 1 0.0000
448 LABORATORY TEST ABNORMAL 1 0.0000
449 RENAL INJURY 1 0.0000
450 HEPATIC FAILURE 1 0.0000
451 NO ADVERSE EVENT 6 0.0000
452 ACUTE KIDNEY INJURY 5 0.0000
453 NERVOUS SYSTEM DISORDER 1 0.0000
454 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
455 RENAL FAILURE 4 0.0000
456 SKIN DISORDER 1 0.0000
457 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
458 NEUTROPENIA 4 0.0000
459 HAEMORRHAGE 3 0.0000
460 DEVICE MALFUNCTION 2 0.0000
461 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
462 DRUG EFFECT INCOMPLETE 1 0.0000
463 RESTLESSNESS 1 0.0000
464 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
465 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
466 RENAL IMPAIRMENT 2 0.0000
467 RENAL FAILURE ACUTE 1 0.0000
468 DYSPNOEA 13 0.0000
469 DEVICE ISSUE 2 0.0000
470 ADVERSE DRUG REACTION 2 0.0000
471 INCORRECT DOSE ADMINISTERED 5 0.0000
472 HYPOKALAEMIA 1 0.0000
473 RENAL DISORDER 1 0.0000
474 CARDIAC DISORDER 2 0.0000
475 SWELLING 2 0.0000
476 COMA 1 0.0000
477 ANAEMIA 4 0.0000
478 PRODUCTIVE COUGH 1 0.0000
479 RASH ERYTHEMATOUS 1 0.0000
480 BLOOD GLUCOSE DECREASED 1 0.0000
481 FLUID RETENTION 1 0.0000
482 CHEST DISCOMFORT 2 0.0000
483 ERYTHEMA 4 0.0000
484 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
485 PLATELET COUNT DECREASED 2 0.0000
486 MALAISE 8 0.0000
487 BLISTER 1 0.0000
488 FLATULENCE 1 0.0000
489 SEIZURE 2 0.0000
490 DISEASE PROGRESSION 2 0.0000
491 PLEURAL EFFUSION 1 0.0000
492 DEEP VEIN THROMBOSIS 1 0.0000
493 AMNESIA 1 0.0000
494 INFUSION RELATED REACTION 1 0.0000
495 INJURY 1 0.0000
496 EPISTAXIS 1 0.0000
497 THROMBOSIS 1 0.0000
498 TREATMENT FAILURE 1 0.0000
499 TOXICITY TO VARIOUS AGENTS 2 0.0000
500 BALANCE DISORDER 1 0.0000
501 DRUG WITHDRAWAL SYNDROME 1 0.0000
502 TACHYCARDIA 1 0.0000
503 ADVERSE EVENT 1 0.0000
504 DRUG INTOLERANCE 1 0.0000
505 HEART RATE INCREASED 1 0.0000
506 HYPERTENSION 2 0.0000
507 PYREXIA 3 0.0000
508 EMOTIONAL DISTRESS 1 0.0000
509 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
510 DEHYDRATION 1 0.0000
511 PAIN IN EXTREMITY 2 0.0000
512 TREMOR 1 0.0000
513 ABDOMINAL DISCOMFORT 1 0.0000
514 MYOCARDIAL INFARCTION 1 0.0000
515 HYPERSENSITIVITY 1 0.0000
516 BLOOD GLUCOSE INCREASED 1 0.0000
517 ALOPECIA 1 0.0000
518 WEIGHT INCREASED 1 0.0000
519 ANXIETY 1 0.0000
520 PRODUCT DOSE OMISSION ISSUE 1 0.0000
521 PAIN 2 0.0000
522 VOMITING 1 0.0000
523 FATIGUE 1 0.0000